Q1 2024 Earnings Summary
- Colgate-Palmolive is achieving strong organic sales growth driven by balanced volume and pricing, with volume growth of 1.3% despite headwinds, and consistent market share gains globally, particularly in Latin America, where Brazil was up double digits and volume growth has been consistent at 0.5%, 5.4%, 8%, and 6.2% over the last four quarters. , ,
- Increased investments in advertising and innovation are delivering positive ROI, leading to volume growth above category rates and accelerating market share gains in Oral Care, with record shares in Europe and growth in Africa and North America. , ,
- The company's focus on gross margin improvement through revenue growth management and funding-the-growth initiatives has resulted in a 310 basis points gross margin increase year-over-year, setting the stage for sustainable earnings per share growth. ,
- Colgate-Palmolive expects organic sales growth to decelerate as the year progresses due to more difficult comparisons and economic uncertainties, including stubbornly high interest rates and foreign exchange headwinds, which could impact future revenue growth.
- Management acknowledges ongoing challenges in North America, with market shares remaining choppy and the need for further work to improve performance, indicating potential difficulties in maintaining or growing market share in this key market.
- The company anticipates escalating raw material inflation and continued foreign exchange volatility may pressure gross margins in upcoming quarters, potentially impacting profitability despite efforts in pricing and cost management.
-
Gross Margin Outlook
Q: How will gross margins progress this year?
A: Gross margins are expected to expand in 2024 despite headwinds like rising raw material costs and FX impacts. Pricing will taper off, but growth will come from funding-the-growth initiatives, positive mix, and scale benefits from returning volume growth. The first quarter saw a 310 basis point year-over-year increase in gross margin, and the company is confident in delivering margin expansion for the year. -
Organic Sales Guidance
Q: Why expect organic sales to decelerate as comps ease?
A: Comps become more difficult as the year progresses due to previous pricing actions. Pricing will slow in the back half, and it's uncertain how much will convert to volume. Economic uncertainties like FX headwinds and high interest rates persist. Nonetheless, the company remains confident in its guidance and strategy but aims to maintain operational flexibility. -
Hill's Pet Nutrition Outlook
Q: What's driving Hill's volume improvement and outlook?
A: Hill's performed well in a tough environment, with volume nearly flat excluding private label impact and sequentially up. The business grew high single digits excluding private label, with strong share growth in Science Diet and Prescription Diet. Opportunities exist in wet pet food, especially in cat segments, leveraging new manufacturing to drive growth and improve margins over time. -
North America Performance
Q: Explain North America's volume growth and market share.
A: North America saw its best volume growth in nearly two years, driven by better execution of innovation and promotional strategies, boosting volume share in toothpaste and toothbrushes. While value shares are a bit choppy, the strategy focuses on improving margins and reinvesting to drive market share. Non-Nielsen channels are growing rapidly, contributing to overall health. -
Advertising Spend and ROI
Q: What's your strategy on increasing ad spend and ROI?
A: The company is seeing terrific ROI from increased advertising spend, translating into volume growth and consistent share gains. There's a focus on using data and analytics to improve personalization and ROI. Investment is broad-based across the portfolio, not just in Oral Care and Pet, leading to strong performance in brands like Sanex in Europe. The company will continue investing to keep brands vibrant and drive consistent growth. -
Europe Performance
Q: Discuss Europe's strong numbers and private label impact.
A: Europe had a great quarter with broad-based growth and positive volume despite ongoing pricing. Growth opportunities are driven by innovations in Oral Care and Personal Care, with record shares for meridol and elmex. Private label penetration is higher in Europe, with some acceleration in home care categories, but the company continues to grow by broadening investment across more brands. -
Consumer Behavior in U.S. and China
Q: How is consumer behavior affecting your strategy?
A: Consumers have been constructive despite inflation. The company balances affordability and premiumization by innovating in both entry-level and premium products. In China, while rural consumers are challenged, the premium segment is robust. The Darlie franchise is well-positioned, and Colgate's move to premium offerings and e-commerce has led to a terrific quarter in China. -
Cash Flow and CapEx
Q: Outlook on cash flow, CapEx, and capital allocation?
A: Cash flow performance is strong, with slight year-over-year decline due to timing issues. CapEx as a percentage of sales is expected to be lower than last year. Leverage improved to 1.8x, and a $500 million bond was paid back with commercial paper due to strong cash flow. Capital allocation priorities remain investing in the business, returning to shareholders, and pursuing M&A opportunities. -
Oral Care Market Share
Q: What's driving Oral Care market share growth?
A: Global market share growth in Oral Care, especially in the Whitening segment, is a result of strategic execution over recent years. Record shares in Europe are due to investments in therapeutic brands like elmex and meridol. Growth is broad-based across regions, driven by innovation and increased spending. -
FX and Raw Material Headwinds
Q: How are FX and raw material costs impacting margins?
A: Raw material inflation is expected to slightly escalate as the year progresses, and FX transactional impacts are a headwind. Actions like sourcing changes and pricing adjustments are mitigating these effects. Funding-the-growth initiatives and revenue growth management are helping to offset headwinds and support margin expansion.